Veer Global Infraconstruction Limited (BOM:543241)

Orchard Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 24, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,223	2,201	2,501	1,064	1,581	223
Market Cap Growth	-12.01%	-12.01%	135.12%	-32.69%	608.22%	-
Enterprise Value	2,338	2,316	2,488	1,059	1,707	215
Last Close Price	136.85	135.50	154.00	72.78	104.86	15.31
PE Ratio	122.19	121.73	170.83	148.74	404.17	115.05
PS Ratio	19.11	18.93	16.23	9.35	20.36	1.72
PB Ratio	6.46	6.40	7.67	3.42	7.82	1.47
P/TBV Ratio	6.46	6.40	7.67	3.42	7.82	1.48
EV/Sales Ratio	20.11	19.91	16.14	9.30	22.00	1.66
EV/EBITDA Ratio	56.06	55.52	144.78	104.97	311.44	78.36
EV/EBIT Ratio	56.87	56.32	148.66	107.94	313.90	80.11
Debt / Equity Ratio	0.49	0.49	0.29	0.01	0.01	0.10
Debt / EBITDA Ratio	4.05	4.05	5.58	0.36	0.35	5.42
Asset Turnover	0.15	0.15	0.24	0.23	0.19	0.38
Inventory Turnover	0.29	0.29	0.80	0.58	0.46	1.06
Quick Ratio	1.09	1.09	0.86	0.86	0.75	0.85
Current Ratio	2.80	2.80	2.33	2.34	1.67	1.78
Return on Equity (ROE)	5.40%	5.40%	4.59%	2.79%	2.21%	1.52%
Return on Assets (ROA)	3.36%	3.36%	1.64%	1.23%	0.83%	0.49%
Return on Capital (ROIC)	5.50%	5.50%	2.84%	2.36%	1.83%	1.24%
Return on Capital Employed (ROCE)	8.00%	8.00%	4.00%	3.10%	2.70%	1.60%
Earnings Yield	0.81%	0.82%	0.58%	0.67%	0.25%	0.87%
FCF Yield	-2.52%	-2.55%	-3.30%	-0.42%	-2.02%	-26.43%
Dividend Yield	-	-	-	-	0.10%	0.33%
Payout Ratio	-	-	-	20.44%	16.62%	66.96%
Buyback Yield / Dilution	0.78%	0.78%	-0.17%	-11.09%	-12.51%	-37.01%
Total Shareholder Return	-	0.78%	-0.17%	-11.09%	-12.42%	-36.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.